Raphael Pharmaceutical Inc. Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was $39.00K.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was $8.00K.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-03-31 was $197.00K.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2025 was $245.00K, a 30.00% decline from fiscal 2024.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2024 was $350.00K.
- Raphael Pharmaceutical Inc. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2022 was $2.09M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2025-12-31 | $245.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $8.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $197.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $350.00K 10-K · filed 2026-03-31 | |
| 2022-12-31 | $2.09M 10-K · filed 2023-03-24 |